risk mitigation
Dotaz
Zobrazit nápovědu
4 strany : tabulky
- Klíčová slova
- hromadné akce, shromažďování,
- MeSH
- bezpečnost MeSH
- COVID-19 prevence a kontrola MeSH
- epidemický výskyt choroby prevence a kontrola MeSH
- hodnocení rizik MeSH
- koronavirové infekce prevence a kontrola MeSH
- Konspekt
- Veřejné zdraví a hygiena
- NLK Obory
- veřejné zdravotnictví
- epidemiologie
- NLK Publikační typ
- publikace WHO
Health in the green economy
viii, 122 s. : il. ; 30 cm
- MeSH
- bydlení normy MeSH
- environmentální zdraví MeSH
- hodnocení rizik MeSH
- klimatické změny MeSH
- zachování přírodních zdrojů MeSH
- Konspekt
- Veřejné zdraví a hygiena
- NLK Obory
- environmentální vědy
- NLK Publikační typ
- publikace WHO
9 stran : grafy
- MeSH
- cestovní lékařství MeSH
- COVID-19 MeSH
- epidemický výskyt choroby MeSH
- hodnocení rizik MeSH
- koronavirové infekce MeSH
- mezinárodní spolupráce MeSH
- testování na COVID-19 MeSH
- Konspekt
- Veřejné zdraví a hygiena
- NLK Obory
- veřejné zdravotnictví
- NLK Publikační typ
- publikace WHO
Environmental risks of human pharmaceutical products should be made transparent and mitigated as far as possible. We propose to apply a risk mitigation scheme to the marketing authorisation of human medicinal products which is pragmatic and tailored, and thus will not increase the burden to regulators and industry too much. This scheme takes into account increasing knowledge and accuracy of the environmental risk estimates, applying preliminary risk mitigation when risks are determined based on model estimates, and definitive, more strict and far-reaching risk mitigation when risks are based on actual measured environmental concentrations. Risk mitigation measures should be designed to be effective, proportional, easy to implement, and in line with current (other) legislation, as well as not being a burden to the patient/health care professionals. Furthermore, individual risk mitigation measures are proposed for products showing environmental risks, while general risk mitigation measures can be applied to all products to reduce the overall burden of pharmaceuticals in the environment. In order to effectively mitigate risk, linking marketing authorisation legislation to environmental legislation is essential.
- MeSH
- léčivé přípravky * MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The Radon program in the Czech Republic has a relatively long and rich history. Procedures, which enable to evaluate the risk of radon penetration from the ground, to protect new buildings, to find existing buildings with elevated indoor radon levels and to realise remedial measures in such buildings, have been developed, published and tested. In some cases, the whole system may fail due to psychological or sociological reasons. Three types of problems (conflicts) will be presented: human behaviour affecting measurement results, conflict between individual and 'all-society' points of view, interpretation of radon risk itself.
INTRODUCTION: Radon is a major indoor air pollutant that poses a significant risk of lung cancer to those exposed in their homes. While mitigation of high radon levels in homes has been shown to be effective, home mitigation rates remain low. This study examines the barriers and facilitators to radon mitigation in homes from the perspectives of authorities responsible for radon risk management, the mitigation industry (contractors), and residents in four European countries (Belgium, Ireland, Slovenia, and the UK) with high radon risks and low mitigation rates. METHODS: A multi-method approach was used to gather data from various stakeholders, including online surveys, content analysis of legal documents, group interviews, workshops, and focus groups. RESULTS: Authorities, contractors, and residents identified various facilitators to radon mitigation, including legal requirements for mitigation, awareness campaigns, low mitigation costs, availability of financial support, accreditation of mitigation contractors, and a perception of radon as a health threat. However, barriers to mitigation were also identified, such as a lack of awareness, fragmented mitigation processes, and inadequate communication between stakeholders. DISCUSSION: The study highlights the complexity of the radon mitigation process and suggests that interventions aimed at increasing mitigation rates should target stakeholders beyond just residents, such as constructors, health professionals, and policy makers. An integrated approach to radon mitigation, from policy to provision, is necessary to effectively lower levels of this indoor air pollutant.
- MeSH
- akreditace MeSH
- látky znečišťující vzduch * MeSH
- lidé MeSH
- průmysl MeSH
- radon * MeSH
- správní úředníci MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Microbiological risk assessment series, ISSN 1726-5274 No. 12
xxv, 132 s. : tab., grafy ; 24 cm
- Konspekt
- Mikrobiologie
- NLK Obory
- mikrobiologie, lékařská mikrobiologie
- hygiena
- zemědělství a potravinářství
- NLK Publikační typ
- publikace WHO
Microbiological risk assessment series, ISSN 1726-5274 No. 11
xv, 35 s. : tab., grafy ; 24 cm
- Konspekt
- Mikrobiologie
- NLK Obory
- mikrobiologie, lékařská mikrobiologie
- hygiena
- zemědělství a potravinářství
- NLK Publikační typ
- publikace WHO
6 stran
- MeSH
- Betacoronavirus MeSH
- cestovní lékařství MeSH
- COVID-19 MeSH
- epidemický výskyt choroby MeSH
- epidemiologické monitorování MeSH
- mezinárodní spolupráce MeSH
- řízení rizik MeSH
- testování na COVID-19 MeSH
- Konspekt
- Veřejné zdraví a hygiena
- NLK Obory
- infekční lékařství
- cestovní a tropická medicína
- veřejné zdravotnictví
- NLK Publikační typ
- publikace WHO
... framework -- 03 -- Annexes -- Annex 1 Methodology -- Annex 2 Supporting RCCE guidance documents Annex 3 Risk ... ... for COVID-19 Annex 5 The RCCE Collective Service -- Acknowledgments -- References -- COVID-19 Global Risk ...
46 stran : ilustrace
- MeSH
- Betacoronavirus MeSH
- COVID-19 MeSH
- epidemický výskyt choroby MeSH
- komunikace MeSH
- riziko MeSH
- účast komunity MeSH
- Konspekt
- Veřejné zdraví a hygiena
- NLK Obory
- veřejné zdravotnictví
- NLK Publikační typ
- publikace WHO
